drugset / Trial / NCT02370043

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791

NCT02370043 ↗

Phase 1 Completed 19 enrolled Kaneq Bioscience Limited
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to assess the safety, tolerability, and the effect of food on KQ-791. Each participant may receive up to 3 single doses of KQ-791 (at up to 3 different dose levels) and 1 placebo dose over the course of the study. Up to 6 escalating dose levels may be studied, in two distinct groups or cohorts.

Timeline

Start
2015-02
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject KQ-791 Unknown 15 mg Oral

Indications

No indication recorded.